Copyright: ©Author(s) 2026.
World J Dermatol. Sep 16, 2026; 12(1): 121180
Published online Sep 16, 2026. doi: 10.5314/wjd.121180
Published online Sep 16, 2026. doi: 10.5314/wjd.121180
Figure 1 Kaplan-Meier curves.
A: Showing overall treatment persistence in patients with moderate-to-severe psoriasis treated with secukinumab or guselkumab during the study follow-up period; B: Showing treatment persistence with secukinumab according to prior biologic exposure, comparing biologic-naïve and biologic-experienced patients; C: Showing treatment persistence with guselkumab according to prior biologic exposure, comparing biologic-naïve and biologic-experienced patients.
- Citation: Borrás-Blasco J, Valcuende-Rosique A, Alcala R, Cornejo-Uixeda S. Long-term persistence comparison between guselkumab and secukinumab for the treatment of psoriasis. World J Dermatol 2026; 12(1): 121180
- URL: https://www.wjgnet.com/2218-6190/full/v12/i1/121180.htm
- DOI: https://dx.doi.org/10.5314/wjd.121180